Chapter 11. How to Promote Quality Use of Cost-Effective Medicines

  1. Nick Freemantle1 and
  2. Suzanne Hill2
  1. Hans Hogerzeil and
  2. Kathleen Holloway

Published Online: 5 NOV 2007

DOI: 10.1002/9780470994719.ch11

Evaluating Pharmaceuticals for Health Policy and Reimbursement

Evaluating Pharmaceuticals for Health Policy and Reimbursement

How to Cite

Hogerzeil, H. and Holloway, K. (2004) How to Promote Quality Use of Cost-Effective Medicines, in Evaluating Pharmaceuticals for Health Policy and Reimbursement (eds N. Freemantle and S. Hill), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470994719.ch11

Editor Information

  1. 1

    Department of Primary Care and General Practice, University of Birmingham,Birmingham,UK

  2. 2

    Faculty of Health,University of Newcastle,Newcastle, Australia

Publication History

  1. Published Online: 5 NOV 2007
  2. Published Print: 1 AUG 2004

ISBN Information

Print ISBN: 9780727917843

Online ISBN: 9780470994719

SEARCH

Keywords:

  • cost-effective medicine;
  • quality use;
  • pharmaceutical industry;
  • medical costs;
  • clinical guidelines

Summary

This chapter contains sections titled:

  • Introduction

  • Local practice guidelines

  • Medicines and therapeutics committees

  • Supervision, audit, and feedback

  • Undergraduate training in prescribing skills

  • Continuing medical education

  • Ethical promotion

  • Generic policies

  • Financial incentives

  • Appropriate regulation

  • Conclusion

  • Acknowledgement

  • References